48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO)

NCT03845075 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypothalamic Injury-induced Obesity (HIO)

Interventions

DRUG: Tesofensine/Metoprolol
DRUG: Placebo

Sponsor

Saniona